生命科学分析市场、机会、成长动力、产业趋势分析与预测，2024-2032

2023 年，全球生命科学分析市场估值为 157 亿美元，预计 2024 年至 2032 年复合年增长率为 8.2%，这主要得益于临床试验中分析解决方案的日益采用以及个性化药物的需求。

一个关键驱动因素是在临床试验中越来越多地使用分析解决方案，解决临床研究日益复杂的问题。这些解决方案提供即时见解、完善试验设计并增强决策能力，从而产生更有效的结果。例如，Pharma Intelligence 2023 年的一项研究发现，65% 使用进阶分析的临床试验申办者的试验效率提高了 25%，包括更快的患者招募和更精确的资料分析。

技术创新正在提高生命科学分析的效率。人工智慧和机器学习整合完善了预测建模和资料解释，可以对大量资料集进行细緻分析，并揭示影响药物开发和个人化治疗策略的模式。

整个生命科学分析产业根据组件、类型、应用程式、部署模式、最终用途和区域进行分类。

服务领域在 2023资料以 91 亿美元的收入引领市场。服务提供者设计、实施和管理这些解决方案，提供持续的支援、更新和维护，以确保最佳效能，促进该细分市场的成长。

2023 年，销售和行销支援部门以 36 亿美元的收入位居营收榜首。生命科学公司依靠分析来衡量市场趋势、了解客户行为并评估竞争动态。销售和行销分析的洞察力使公司能够制定有针对性的行销策略、完善销售方法并发现新兴市场机会。个人化、数据驱动的行销增强了客户参与度并提高了转换率，从而推动了该细分市场的成长。

2023 年，北美以 670 万美元的收入主导生命科学分析市场，预计 2024 年至 2032 年复合年增长率为 7.7%。提供者和生命科学公司利用资料分析来做出更好的决策和改善患者的治疗结果。北美在研发方面的大量投资，特别是在生物技术和製药方面，扩大了对促进创新和简化药物开发的分析工具的需求。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

• 产业生态系统分析
• 产业影响力
  • 成长动力
    • 在临床试验中越来越多地采用分析解决方案
    • 对个人化药物的需求不断增长
    • 分析在生命科学产业的渗透率不断提高
    • 分析解决方案技术进步的崛起
  • 产业陷阱与挑战
    • 实施成本高
    • 资料隐私和窃盗问题
• 成长潜力分析
• 监管环境
• 创新格局
• 启动场景
• 波特的分析
• PESTEL分析
• 未来市场趋势
• 差距分析

第 4 章：竞争格局

• 介绍
• 公司矩阵分析
• 主要参与者的竞争分析
• 竞争定位矩阵
• 战略仪表板

第 5 章：市场估计与预测：按组成部分，2021 - 2032 年

• 主要趋势
• 服务
• 软体

第 6 章：市场估计与预测：按类型，2021 - 2032

• 主要趋势
• 描述性的
• 预测性
• 规定性的

第 7 章：市场估计与预测：按应用分类，2021 - 2032

• 主要趋势
• 销售和行销支持
• 临床试验
• 研究与开发
• 监理合规性
• 供应链分析
• 药物警戒

第 8 章：市场估计与预测：按部署模式，2021 - 2032 年

• 主要趋势
• 基于云端
• 本地

第 9 章：市场估计与预测：按最终用途，2021 - 2032 年

• 主要趋势
• 製药和生物技术公司
• 合约研究组织
• 医疗器材製造商
• 其他最终用户

第 10 章：市场估计与预测：按地区，2021 - 2032

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 荷兰
  • 欧洲其他地区
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
  • 亚太地区其他地区
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 拉丁美洲其他地区
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋
  • 中东和非洲其他地区

第 11 章：公司简介

• Accenture
• Analytics8
• Cognizant
• IBM Corporation
• IQVIA Inc.
• MaxisIT
• Microsoft Corporation
• Optum, Inc.
• Oracle Corporation
• SAS Institute, Inc.
• Sisense Ltd.
• ThoughtSpot Inc.
• Veeva Systems
• Veradigm LLC
• Wipro Limited

The Global Life Science Analytics Market was valued at USD 15.7 billion in 2023 and is projected to grow at a CAGR of 8.2% from 2024 to 2032, fueled by the rising adoption of analytical solutions in clinical trials and the demand for personalized medicines.

One key driver is the increasing use of analytical solutions in clinical trials, addressing the growing complexity of clinical research. These solutions provide real-time insights, refine trial designs, and enhance decision-making, leading to more efficient outcomes. For example, a 2023 study by Pharma Intelligence found that 65% of clinical trial sponsors using advanced analytics saw a 25% boost in trial efficiency, including quicker patient recruitment and more precise data analysis.

Technological innovations are enhancing the efficiency of life science analytics. AI and machine learning integration refines predictive modeling and data interpretation, allowing meticulous analysis of vast datasets and revealing patterns that influence drug development and personalized treatment strategies.

The overall life science analytics industry is classified based on component, type, application, deployment mode, end-use, and region.

The services segment led the market with a revenue of USD 9.1 billion in 2023. Life sciences companies seek bespoke analytics solutions tailored to their research demands, regulatory standards, and data intricacies. Service providers design, implement, and manage these solutions, offering continuous support, updates, and maintenance to ensure optimal performance, bolstering the segment's growth.

In 2023, the sales and marketing support segment topped the revenue charts with USD 3.6 billion. Life sciences firms rely on analytics to gauge market trends, understand customer behavior, and assess competitive dynamics. Insights from sales and marketing analytics empower companies to craft targeted marketing strategies, refine sales approaches, and spot emerging market opportunities. Personalized, data-driven marketing enhances customer engagement and boosts conversion rates, propelling the segment's growth.

In 2023, North America dominated the life science analytics market with a revenue of USD 6.7 million and is projected to grow at a CAGR of 7.7% from 2024 to 2032. The region's advanced healthcare infrastructure facilitates the adoption of cutting-edge analytics solutions, allowing healthcare providers and life sciences firms to harness data analytics for better decision-making and patient outcomes. North America's substantial investments in R&D, especially in biotechnology and pharmaceuticals, amplify the demand for analytics tools that foster innovation and streamline drug development.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360-degree synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Growing adoption of analytical solutions in clinical trials
    • 3.2.1.2 Rising demand for personalized medicines
    • 3.2.1.3 Increasing penetration of analytics in life science industry
    • 3.2.1.4 Rise in technological advancements in analytical solutions
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High implementation cost
    • 3.2.2.2 Data privacy and theft issues
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Innovation landscape
• 3.6 Start-up scenario
• 3.7 Porter's analysis
• 3.8 PESTEL analysis
• 3.9 Future market trends
• 3.10 Gap analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Competitive analysis of major key players
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Component, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Services
• 5.3 Software

Chapter 6 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Descriptive
• 6.3 Predictive
• 6.4 Prescriptive

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Sales and marketing support
• 7.3 Clinical trials
• 7.4 Research and development
• 7.5 Regulatory compliance
• 7.6 Supply chain analytics
• 7.7 Pharmacovigilance

Chapter 8 Market Estimates and Forecast, By Deployment Mode, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 Cloud-based
• 8.3 On-premises

Chapter 9 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

• 9.1 Key trends
• 9.2 Pharmaceutical and biotech companies
• 9.3 Contract research organizations
• 9.4 Medical device manufacturers
• 9.5 Other end-users

Chapter 10 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 10.1 Key trends
• 10.2 North America
  • 10.2.1 U.S.
  • 10.2.2 Canada
• 10.3 Europe
  • 10.3.1 Germany
  • 10.3.2 UK
  • 10.3.3 France
  • 10.3.4 Spain
  • 10.3.5 Italy
  • 10.3.6 Netherlands
  • 10.3.7 Rest of Europe
• 10.4 Asia Pacific
  • 10.4.1 China
  • 10.4.2 Japan
  • 10.4.3 India
  • 10.4.4 Australia
  • 10.4.5 South Korea
  • 10.4.6 Rest of Asia Pacific
• 10.5 Latin America
  • 10.5.1 Brazil
  • 10.5.2 Mexico
  • 10.5.3 Argentina
  • 10.5.4 Rest of Latin America
• 10.6 Middle East and Africa
  • 10.6.1 South Africa
  • 10.6.2 Saudi Arabia
  • 10.6.3 UAE
  • 10.6.4 Rest of Middle East and Africa

Chapter 11 Company Profiles

• 11.1 Accenture
• 11.2 Analytics8
• 11.3 Cognizant
• 11.4 IBM Corporation
• 11.5 IQVIA Inc.
• 11.6 MaxisIT
• 11.7 Microsoft Corporation
• 11.8 Optum, Inc.
• 11.9 Oracle Corporation
• 11.10 SAS Institute, Inc.
• 11.11 Sisense Ltd.
• 11.12 ThoughtSpot Inc.
• 11.13 Veeva Systems
• 11.14 Veradigm LLC
• 11.15 Wipro Limited